Literature DB >> 24366837

In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patients.

James M Stevenson1, Michael Heung, A Mary Vilay, Rachel F Eyler, Chirag Patel, Bruce A Mueller.   

Abstract

PURPOSE: To examine the impact of continuous renal replacement therapy (CRRT) on glucose kinetics and therefore caloric balance.
METHODS: In vitro experiments were conducted to characterize glucose kinetics in a variety of CRRT modalities and prescriptions. Additional experiments evaluated the impact of citrate anticoagulation using anti-coagulant dextrose solution A (ACD-A) on CRRT glucose movement. A formula was developed to predict the glucose delivery to/from the patient per day of CRRT, and this data was extrapolated to determine the net caloric impact of CRRT.
RESULTS: A total of 104 experiments were conducted with an overall glucose extraction coefficient of 1.04 (95% CI 1.03-1.05). CRRT-related glucose removal was directly related to effluent (dialysate and/or hemofiltration) rate and pre-filter blood glucose concentration, and inversely related to dialysis solution glucose concentration. In all modalities tested, CRRT resulted in a net negative glucose balance, with estimated caloric losses ranging between 20 kcal and 550 kcal depending on the conditions tested. The addition of ACD-A resulted in net glucose delivery in some conditions and a positive caloric balance of up to 470 kcal per day.
CONCLUSIONS: CRRT can have a significant effect on glucose balance and result in either significant daily caloric gains or losses, and this effect can be predicted based on CRRT prescription and patient characteristics. Clinicians should be aware of this potential impact when prescribing nutritional therapy to patients undergoing CRRT, as an imbalance in caloric feeding can adversely affect outcomes in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366837     DOI: 10.5301/ijao.5000232

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

1.  Euglycemic ketoacidosis, a common and underecognized complication of continuous renal replacement therapy using glucose-free solutions.

Authors:  Maxime Coutrot; Guillaume Hékimian; Thibaut Moulin; Nicolas Bréchot; Matthieu Schmidt; Sébastien Besset; Ania Nieszkowska; Guillaume Franchineau; Simon Bourcier; Olivier Bourron; Charles-Edouard Luyt; Alain Combes
Journal:  Intensive Care Med       Date:  2018-03-13       Impact factor: 17.440

2.  Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis.

Authors:  Joop Jonckheer; Alex Van Hoorn; Taku Oshima; Elisabeth De Waele
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

3.  The effect of continuous venovenous hemodiafiltration on amino acid delivery, clearance, and removal in children.

Authors:  Richard P Lion; Molly R Vega; E O'Brien Smith; Sridevi Devaraj; Michael C Braun; Nathan S Bryan; Moreshwar S Desai; Jorge A Coss-Bu; Talat Alp Ikizler; Ayse Akcan Arikan
Journal:  Pediatr Nephrol       Date:  2021-08-12       Impact factor: 3.714

4.  The association of intravenous insulin and glucose infusion with intensive care unit and hospital mortality: a retrospective study.

Authors:  Sigrid C van Steen; Saskia Rijkenberg; Peter H J van der Voort; J Hans DeVries
Journal:  Ann Intensive Care       Date:  2019-02-11       Impact factor: 6.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.